B. Raungaard

C. Terkelsen, T. Thim, M. Maeng, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Randomized clinical comparison of the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent with the sirolimus‐eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical

C. Terkelsen, S. Jensen, M. Maeng, 2018, American heart journal.

Comparison of Acute Versus Subacute Coronary Angiography in Patients With NON-ST-Elevation Myocardial Infarction (from the NONSTEMI Trial).

C. Terkelsen, H. Bøtker, M. Maeng, 2019, The American journal of cardiology.

Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation.

H. Bøtker, T. Thim, J. Eikelboom, 2019, The American journal of cardiology.

Functional characterization of two low density lipoprotein receptor gene mutations by fluorescence flow cytometric assessment of receptor activity in stimulated human T‐lymphocytes

B. Raungaard, O. Færgeman, Henrik Kjærulf Jensen, 2000, Clinical genetics.

Flow cytometry with a monoclonal antibody to the low density lipoprotein receptor compared with gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia.

O. Faergeman, B. Raungaard, H. Jensen, 1998, Clinical chemistry.

Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.

E. Mirrakhimov, Gani Bajraktari, T. Marandi, 2021, European heart journal.

Angiographic outcome in patients treated with deferred stenting after ST-segment elevation myocardial infarction-results from DANAMI-3-DEFER.

C. Terkelsen, L. Køber, S. Jensen, 2022, European heart journal. Acute cardiovascular care.

Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention.

C. Terkelsen, L. Køber, S. Jensen, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial).

H. Bøtker, S. Jensen, M. Maeng, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus [Response to Letter]

H. Bøtker, H. Sørensen, T. Thim, 2019, Clinical epidemiology.

Chronic total coronary occlusion: treatment results

L. Thuesen, A. Villadsen, B. Raungaard, 2017, Scandinavian cardiovascular journal : SCJ.

Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent

C. Terkelsen, T. Thim, M. Maeng, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100.

O. Faergeman, B. Raungaard, P. Hansen, 2000, Clinical chemistry.

Coronary artery disease and risk of adverse cardiac events and stroke

G. Lip, H. Bøtker, H. Sørensen, 2017, European Journal of Clinical Investigation.

Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study.

L. Køber, T. Engstrøm, L. Holmvang, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Severe Mental Illness and Clinical Outcome After Primary Percutaneous Coronary Intervention.

C. Terkelsen, K. Veien, S. Jensen, 2017, The American journal of cardiology.

Impact of diabetes on 1‐year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial

K. Veien, S. Jensen, T. Engstrøm, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention

C. Terkelsen, H. Bøtker, T. Thim, 2020, Circulation.

Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease: A study from the Western Denmark Heart Registry

H. Bøtker, T. Thim, M. Maeng, 2020, Diabetes & vascular disease research.

Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus

H. Bøtker, H. Sørensen, T. Thim, 2019, Clinical epidemiology.

Association between anti-diabetes treatments and cardiovascular risk in diabetes patients with and without coronary artery disease

H. Bøtker, H. Sørensen, T. Thim, 2019, Diabetes & vascular disease research.

CLEP_A_200173 419..428

H. Bøtker, H. Sørensen, T. Thim, 2019 .

Risk of Myocardial Infarction in Patients Without Angiographic Coronary Artery Disease Compared With the General Population.

H. Bøtker, H. Sørensen, T. Thim, 2020, The American journal of cardiology.

Everolimus-Eluting Versus Biolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus.

C. Terkelsen, H. Bøtker, T. Thim, 2019, The American journal of cardiology.

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents.

C. Terkelsen, H. Bøtker, S. Jensen, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.

C. Terkelsen, H. Bøtker, K. Veien, 2017, JACC. Cardiovascular interventions.

Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial).

C. Terkelsen, H. Bøtker, T. Thim, 2019, JACC. Cardiovascular interventions.

Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial

C. Terkelsen, H. Bøtker, A. Kaltoft, 2016, Circulation. Cardiovascular interventions.

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

C. Terkelsen, H. Bøtker, A. Kaltoft, 2015, The Lancet.

Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004–2016

M. Maeng, P. Poulsen, B. Raungaard, 2021, BMC Cardiovascular Disorders.

Elevated Atherosclerosis-Related Gene Expression, Monocyte Activation and Microparticle-Release Are Related to Increased Lipoprotein-Associated Oxidative Stress in Familial Hypercholesterolemia

Aase Handberg, H. Beck-Nielsen, A. Handberg, 2015, PLoS ONE.

Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents: two-year outcomes of the randomised SORT OUT IX trial.

M. Maeng, E. Christiansen, B. Raungaard, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial.

H. Bøtker, S. Jensen, T. Engstrøm, 2019, American heart journal.

Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment

H. Bøtker, H. Sørensen, T. Thim, 2017, Diabetes Care.

Flow Cytometric Assessment of Effects of Fluvastatin on Low‐Density Lipoprotein Receptor Activity in Stimulated T‐Lymphocytes from Patients with Heterozygous Familial Hypercholesterolemia

B. Raungaard, O. Færgeman, H. Jensen, 2000, Journal of clinical pharmacology.

Co-registration of optical coherence tomography and X-ray angiography in percutaneous coronary intervention. the Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) fusion study.

Shengxian Tu, Johan H C Reiber, Evald Høj Christiansen, 2013, International journal of cardiology.

Effectiveness and Safety of Ticagrelor Implementation in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: A Cohort Study in Western Denmark

H. Sørensen, T. Thim, M. Maeng, 2022, The Lancet regional health. Europe.

Impact of diabetes on clinical outcomes after revascularization with sirolimus‐eluting and biolimus‐eluting stents with biodegradable polymer from the SORT OUT VII trial

C. Terkelsen, H. Bøtker, K. Veien, 2018, Catheterization and cardiovascular interventions.

Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI.

C. Terkelsen, L. Køber, T. Engstrøm, 2019, International journal of cardiology.

Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention

C. Terkelsen, H. Bøtker, T. Thim, 2021, Circulation.

Clinical outcomes three-year after revascularization with biodegradable polymer stents: ultrathin-strut sirolimus-eluting stent versus biolimus-eluting stent: from the Scandinavian organization for randomized trials with clinical outcome VII trial

H. Bøtker, S. Jensen, M. Maeng, 2020, Coronary artery disease.

Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial

C. Terkelsen, K. Veien, M. Maeng, 2021, Circulation. Cardiovascular interventions.

Impact of percutaneous intervention compared to pharmaceutical therapy on complex arrhythmias in patients with chronic total coronary occlusion. Rationale and design of the CTO-ARRHYTHMIA study.

T. Steigen, L. Thuesen, P. Søgaard, 2023, Cardiovascular revascularization medicine : including molecular interventions.

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

Scott A. Prentice, B. Prendergast, C. Terkelsen, 2019, Lancet.

C. Terkelsen, H. Bøtker, A. Kaltoft, 2016, Circulation. Cardiovascular interventions.

Flow cytometric assessment of LDL receptor activity in peripheral blood mononuclear cells compared to gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia.

O. Faergeman, B. Raungaard, H. Jensen, 1999, Cytometry.

Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.

C. Terkelsen, K. Veien, M. Maeng, 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia

H. Beck-Nielsen, A. Handberg, B. Raungaard, 2016, Oxidative medicine and cellular longevity.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.

University of Southern Denmark Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention Rationale and design of the randomized SORT OUT IX trial

S. Jensen, M. Maeng, J. Lassen, 2019 .

Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease

H. Bøtker, B. Raungaard, L. Jensen, 2020, European Heart Journal.

TCT-261 Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer. From the SORT OUT VII Trial.

H. Bøtker, K. Veien, S. Jensen, 2016, Journal of the American College of Cardiology.